SCHEMBL26923233

SCHEMBL26923233

O=C(Nc1ccc(Oc2ccnc(C(=O)NCc3ccccc3)c2)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 11/20 0.78
GSK3B P49841 2/20 0.75
KDR P35968 4/20 0.74
PDGFRB P09619 3/20 0.73
ARAF P10398 2/20 0.73
BRAF P15056 2/20 0.73
RET P07949 2/20 0.73
MEN1 O00255 1/20 0.73
PLK4 O00444 1/20 0.73
CIT O14578 1/20 0.73
AURKA O14965 1/20 0.73
MUSK O15146 1/20 0.73
EPHB6 O15197 1/20 0.73
MAPK13 O15264 1/20 0.73
MLNR O43193 1/20 0.73
MAP3K7 O43318 1/20 0.73
RIPK2 O43353 1/20 0.73
DYRK3 O43781 1/20 0.73
PDE6D O43924 1/20 0.73
NR1I2 O75469 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26921335 0.92 GSK3B (0.78) RAF1GSK3BKDRPDGFRBARAF
SCHEMBL2480623 0.88 RAF1 (0.84) RAF1GSK3BKDRPDGFRBARAF
SCHEMBL13471762 0.88 RAF1 (0.84) RAF1GSK3BKDRPDGFRBARAF
SCHEMBL13471761 0.88 RAF1 (0.84) RAF1GSK3BKDRPDGFRBARAF
SCHEMBL13603517 0.88 RAF1 (0.70) RAF1GSK3BKDRPDGFRBARAF
SCHEMBL3707691 0.88 RAF1 (0.83) RAF1GSK3BKDRPDGFRBARAF
SCHEMBL937568 0.88 RAF1 (1.00) RAF1GSK3BKDRPDGFRBARAF
SCHEMBL22360885 0.87 KDR (0.71) RAF1GSK3BKDRPDGFRBARAF
SCHEMBL13603512 0.87 RAF1 (0.68) RAF1GSK3BKDRPDGFRBARAF
SCHEMBL3407760 0.86 KDR (0.84) RAF1GSK3BKDRPDGFRBARAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240093191-A1 COMPOSITIONS AND METHODS FOR TREATING DISEASE ASSOCIATED WITH DUX4 OVEREXPRESSION RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL (US) 2024-03-21 US disclosed
EP-4288539-A1 COMPOSITIONS AND METHODS FOR TREATING DISEASE ASSOCIATED WITH DUX4 OVEREXPRESSION Research Institute at Nationwide Children's Hospital (US) 2023-12-13 EP disclosed
WO-2022169922-A1 COMPOSITIONS AND METHODS FOR TREATING DISEASE ASSOCIATED WITH DUX4 OVEREXPRESSION RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL (US) 2022-08-11 WO disclosed